Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community‐dwelling older patients acutely admitted to hospital? A Norwegian registry‐based study

Investigate the association between anticholinergic (AC) and sedative (SED) drug burden before hospitalization and postdischarge institutionalization (PDI) in community‐dwelling older patients acutely admitted to hospital.

[1]  J. Turgeon,et al.  Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models , 2021, Drugs & Aging.

[2]  G. Selbæk,et al.  Frailty among older patients receiving home care services. , 2021, Tidsskrift for Den Norske Laegeforening.

[3]  T. Stürmer,et al.  Quantifying cumulative anticholinergic and sedative drug load among US Medicare Beneficiaries , 2020, Pharmacoepidemiology and drug safety.

[4]  K. Halvorsen,et al.  The impact of hospitalisation to geriatric wards on the use of medications and potentially inappropriate medications - a health register study , 2020, BMC Geriatrics.

[5]  L. Maia,et al.  Does the institutionalization influence elderly’s quality of life? A systematic review and meta–analysis , 2020, BMC Geriatrics.

[6]  S. Vollset,et al.  The Norwegian Patient Registry and the Norwegian Registry for Primary Health Care: Research potential of two nationwide health-care registries , 2020, Scandinavian journal of public health.

[7]  Jiyun Kang,et al.  Supporting Aging-in-Place Well: Findings From a Cluster Analysis of the Reasons for Aging-in-Place and Perceptions of Well-Being , 2020, Journal of applied gerontology : the official journal of the Southern Gerontological Society.

[8]  M. Steinman,et al.  Comparison of Pharmacy Database Methods for Determining Prevalent Chronic Medication Use , 2019, Medical care.

[9]  K. Bennett,et al.  Impact of drug burden index on adverse health outcomes in Irish community-dwelling older people: a cohort study , 2019, BMC Geriatrics.

[10]  M. Steinman,et al.  A systematic review of methods for determining cross‐sectional active medications using pharmacy databases , 2019, Pharmacoepidemiology and drug safety.

[11]  W. Freidl,et al.  Individual and country-level determinants of nursing home admission in the last year of life in Europe , 2019, PloS one.

[12]  Lisa G. Pont,et al.  Anticholinergic and sedative medication use in older community‐dwelling people: A national population study in the Netherlands , 2019, Pharmacoepidemiology and drug safety.

[13]  K. Taxis,et al.  Long-term exposure to anticholinergic and sedative medications and cognitive and physical function in later life. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  V. Mor,et al.  Drug Burden Index and Its Association With Hip Fracture Among Older Adults: A National Population-Based Study. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  K. Bennett,et al.  Anticholinergic and sedative drug burden in community-dwelling older people: a national database study , 2018, BMJ Open.

[16]  J. Gladman,et al.  Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews , 2018, Drugs & Aging.

[17]  E. Banks,et al.  Ascertainment of self-reported prescription medication use compared with pharmaceutical claims data. , 2017, Public health research & practice.

[18]  J. Starr,et al.  Predicting discharge to institutional long-term care following acute hospitalisation: a systematic review and meta-analysis , 2017, Age and ageing.

[19]  F. Mattace-Raso,et al.  Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients , 2017, Pharmacology research & perspectives.

[20]  P. Krolak-Salmon,et al.  Factors associated with changes in exposure to anticholinergic and sedative medications in elderly hospitalized patients: multicentre longitudinal study , 2017, European journal of neurology.

[21]  Maciej Liskiewicz,et al.  Robust causal inference using Directed Acyclic Graphs: the R package , 2018 .

[22]  K. Taxis,et al.  Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies , 2016, European Journal of Clinical Pharmacology.

[23]  Laura Fratiglioni,et al.  Impact of living alone on institutionalization and mortality: a population-based longitudinal study. , 2016, European journal of public health.

[24]  I. Scott,et al.  A medication review and deprescribing method for hospitalised older patients receiving multiple medications , 2016, Internal medicine journal.

[25]  F. Jacobsen.  Understanding public elderly care policy in Norway: A narrative analysis of governmental White papers. , 2015, Journal of aging studies.

[26]  P. Nishtala,et al.  Associations of drug burden index with falls, general practitioner visits, and mortality in older people , 2014, Pharmacoepidemiology and drug safety.

[27]  A. Mangoni,et al.  Drug Burden Index, Physical Function, and Adverse Outcomes in Older Hospitalized Patients , 2012, Journal of clinical pharmacology.

[28]  A. Engeland,et al.  Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs , 2012, Pharmacoepidemiology and drug safety.

[29]  R. Sulkava,et al.  Drug Burden Index associated with function in community-dwelling older people in Finland: A cross-sectional study , 2012, Annals of medicine.

[30]  H. Sandholzer,et al.  The risk for nursing home admission (NHA) did not change in ten years--a prospective cohort study with five-year follow-up. , 2012, Archives of gerontology and geriatrics.

[31]  S. Lord,et al.  Associations Between Drug Burden Index and Falls in Older People in Residential Aged Care , 2011, Journal of the American Geriatrics Society.

[32]  G. Gigli,et al.  Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients , 2009, Neurological Sciences.

[33]  L. Rodríguez-Mañas,et al.  Effectiveness of acute geriatric units on functional decline, living at home, and case fatality among older patients admitted to hospital for acute medical disorders: meta-analysis , 2009, BMJ : British Medical Journal.

[34]  M. Thorslund,et al.  Care utilisation in the last years of life in relation to age and time to death: results from a Swedish urban population of the oldest old , 2008, European journal of ageing.

[35]  Ian Shrier,et al.  Reducing bias through directed acyclic graphs , 2008 .

[36]  E. Hansen,et al.  Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. , 2008, Journal of clinical epidemiology.

[37]  S. Rubin,et al.  A drug burden index to define the functional burden of medications in older people. , 2007, Archives of internal medicine.

[38]  M. Guha.  The Sage Encyclopedia of Social Science Research Methods , 2005 .

[39]  S. Kivelä,et al.  A model to classify the sedative load of drugs , 2003, International journal of geriatric psychiatry.

[40]  H. S. Lau,et al.  Validation of pharmacy records in drug exposure assessment. , 1997, Journal of clinical epidemiology.

[41]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[42]  H. Jamieson,et al.  Drug Burden and its Association with Falls Among Older Adults in New Zealand: A National Population Cross-Sectional Study , 2017, Drugs & Aging.

[43]  Elmar Brähler,et al.  Prediction of institutionalization in the elderly. A systematic review. , 2010, Age and ageing.

[44]  K. Furu.  Establishment of the nationwide Norwegian Prescription Database (NorPD) – new opportunities for research in pharmacoepidemiology in Norway , 2008 .